Allianz Asset Management GmbH - ADAMAS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$1,276,000
-10.6%
63,744
+15.4%
0.00%0.0%
Q2 2018$1,427,000
+7.4%
55,237
-0.6%
0.00%0.0%
Q1 2018$1,329,000
-26.1%
55,594
+4.7%
0.00%0.0%
Q4 2017$1,799,000
+57.4%
53,081
-1.7%
0.00%0.0%
Q3 2017$1,143,000
+20.3%
54,010
-0.6%
0.00%0.0%
Q2 2017$950,000
-2.2%
54,341
-2.1%
0.00%0.0%
Q1 2017$971,000
+134.0%
55,480
+126.2%
0.00%
Q4 2016$415,000
-17.2%
24,528
-19.7%
0.00%
Q3 2016$501,000
-9.2%
30,559
-16.2%
0.00%
-100.0%
Q2 2016$552,00036,4760.00%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 808,431$3,501,0002.68%
AIGH Capital Management LLC 875,851$3,793,0001.54%
Healthcare Value Capital, LLC 100,000$433,0001.46%
SILVERARC CAPITAL MANAGEMENT, LLC 440,955$1,909,0001.11%
Opaleye Management Inc. 1,487,800$6,442,0000.84%
Worth Venture Partners, LLC 225,106$975,0000.77%
ARMISTICE CAPITAL, LLC 2,742,000$11,873,0000.40%
DELTEC ASSET MANAGEMENT LLC 245,399$1,063,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 278,011$1,204,0000.15%
Mosaic Family Wealth, LLC 91,807$398,0000.13%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders